Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Simon J, Ogrodnik"'
Autor:
Steffen Dietz, Petros Christopoulos, Zhao Yuan, Arlou Kristina Angeles, Lisa Gu, Anna-Lena Volckmar, Simon J. Ogrodnik, Florian Janke, Chiara Dalle Fratte, Tomasz Zemojtel, Marc A. Schneider, Daniel Kazdal, Volker Endris, Michael Meister, Thomas Muley, Erika Cecchin, Martin Reck, Matthias Schlesner, Michael Thomas, Albrecht Stenzinger, Holger Sültmann
Publikováno v:
EBioMedicine, Vol 62, Iss , Pp 103103- (2020)
Background: Targeted therapies (TKI) have improved the prognosis of ALK-rearranged lung cancer (ALK+ NSCLC), but clinical courses vary widely. Early identification and molecular characterisation of treatment failure have key importance for subsequent
Externí odkaz:
https://doaj.org/article/35543e5f53e748e782b1be948db8ee4b
Autor:
Anna-Lena Volckmar, Thomas Muley, Florian Janke, Arlou Kristina Angeles, Holger Sültmann, Steffen Dietz, Chiara Dalle Fratte, Matthias Schlesner, Simon J. Ogrodnik, Tomasz Zemojtel, Erika Cecchin, Lisa Gu, Daniel Kazdal, Zhao Yuan, Volker Endris, Marc A. Schneider, Petros Christopoulos, Michael Thomas, Albrecht Stenzinger, Martin Reck, Michael Meister
Publikováno v:
EBioMedicine, Vol 62, Iss, Pp 103103-(2020)
EBioMedicine
EBioMedicine
Background Targeted therapies (TKI) have improved the prognosis of ALK-rearranged lung cancer (ALK+ NSCLC), but clinical courses vary widely. Early identification and molecular characterisation of treatment failure have key importance for subsequent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::865855500959f13ffab31b6a27a115ae
https://opus.bibliothek.uni-augsburg.de/opus4/files/92409/1-s2.0-S2352396420304795-main.pdf
https://opus.bibliothek.uni-augsburg.de/opus4/files/92409/1-s2.0-S2352396420304795-main.pdf
Autor:
Michael Meister, Martin Reck, Matthias Schlesner, Steffen Dietz, Lisa Gu, Tomasz Zemojtel, Petros Christopoulos, Michael Thomas, Albrecht Stenzinger, Zhao Yuan, Marc A. Schneider, Simon J. Ogrodnik, Volker Endris, Anna-Lena Volckmar, Thomas Muley, Holger Sültmann
Publikováno v:
Clinical Cancer Research. 26:A21-A21
Non-small cell lung cancer (NSCLC) patients with ALK rearrangements are routinely treated with tyrosine kinase inhibitors (TKIs), leading to improved survival. However, clinical courses vary widely and the disease remains incurable. Therefore, early
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e962520086d01364c42105f5912aa7e1
https://doi.org/10.1158/1557-3265.liqbiop20-a21
https://doi.org/10.1158/1557-3265.liqbiop20-a21
Autor:
Steffen, Dietz, Petros, Christopoulos, Lisa, Gu, Anna-Lena, Volckmar, Volker, Endris, Zhao, Yuan, Simon J, Ogrodnik, Tomasz, Zemojtel, Claus-Peter, Heussel, Marc A, Schneider, Michael, Meister, Thomas, Muley, Martin, Reck, Matthias, Schlesner, Michael, Thomas, Albrecht, Stenzinger, Holger, Sültmann
Publikováno v:
Cold Spring Harbor Molecular Case Studies
Genetic rearrangements involving the anaplastic lymphoma kinase (ALK) gene confer sensitivity to ALK tyrosine kinase inhibitors (TKIs) and superior outcome in non-small-cell lung cancer (NSCLC). However, clinical courses vary widely, and recent studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cdf8912efd5324169103bad98cfe0376
https://pubmed.ncbi.nlm.nih.gov/31753813
https://pubmed.ncbi.nlm.nih.gov/31753813
Autor:
Michael Thomas, CP Heußel, Petros Christopoulos, Felix Lasitschka, Stefan Rieken, Volker Endris, Martina Kirchner, M. Elsayed, Michael Meister, Peter Schirmacher, Simon J. Ogrodnik, Steffen Dietz, Thomas Muley, Tomasz Zemojtel, Holger Sültmann, Anna-Lena Volckmar, Helge Bischoff, Albrecht Stenzinger
Publikováno v:
60. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V..
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3802b432a7c1e77f7b003d7819600945
https://doi.org/10.1055/s-0039-1678030
https://doi.org/10.1055/s-0039-1678030
Autor:
Albrecht Stenzinger, Volker Endris, Michael Thomas, Steffen Dietz, Lisa Gu, Tomasz Zemojtel, Matthias Schlesner, Martin Reck, Simon J. Ogrodnik, Petros Christopoulos, Marc A. Schneider, Claus Peter Heussel, Zhao Yuan, Michael Meister, Thomas Muley, Holger Sültmann, Anna-Lena Volckmar
Publikováno v:
Molecular Case Studies. 5:a004630
Genetic rearrangements involving the anaplastic lymphoma kinase (ALK) gene confer sensitivity to ALK tyrosine kinase inhibitors (TKIs) and superior outcome in non-small-cell lung cancer (NSCLC). However, clinical courses vary widely, and recent studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8e43637388537219daa0f0d9e1dec68
https://doi.org/10.1101/mcs.a004630
https://doi.org/10.1101/mcs.a004630
Publikováno v:
Oncology Research & Treatment. 2020Supplement1, Vol. 43, p1-265. 265p.